Cohort and Cross Sectional Studies Flashcards

1
Q

<p>How are participants chosen in a cohort study?</p>

A

<p>-two groups are chosen based on their exposure status

- follow these groups over a period of time to see if they develop the outcome
- measure exposure before disease has happened
- at baseline no one has experienced outcome </p>

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

<p>How does cohort study design impact temporal relationship?</p>

A

<p>-measure exposure before we know what happens to person at end of the study
-can make temporal judgment that exposure preceded the outcome (unlike case control study)</p>

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

<p>When are cohort studies useful?</p>

A

<p>-when time between exposure and disease is relatively short (look at chronic disease like diabetes or heart disease)

- low risk that people who enroll will leave the study (if we enroll lots of people but we can't follow most for at least a year you don't get much info)
- when adequate funding to continue study is available</p>

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

<p>What is a retrospective cohort study?</p>

A

<p>-all of the data have already been collected

- look back in the past to recreate what exposure histories may be
- 2 groups
- look for exposure in past then look for disease after baseline measure was taken </p>

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

<p>When do we use retrospective cohort studies?</p>

A

<p>-no losses to follow up

- temporality is still preserved (info on exposure is collected before anyone becomes diseased)</p>

  • when extremely long follow up times are required to assess the relation between exposure and outcome
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

<p>Compare case control, prospective and retrospective cohort studies</p>

A

<p>case control: researches select cases and controls based on the presence or absence of the outcome respectively and look back in time for disproportionate exposures
prospective studies: follow groups defined by different exposures and observe the incidence of the outcomes
retrospective: researcher starts the study at the time follow up has already been completed </p>

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

<p>Where to look for data for retrospective cohort studies?</p>

A

<p>-databases, drug utilization databases, hospital records, death certificates
-problems: no control over completion or accuracy of records and historical effect (advances in medicine may render some data obsolete)</p>

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

<p>What is proper conduct with the use of a database?</p>

A

<p>-form hypothesis, then look for variables in dataset and do analyses
-compared to improper conduct of randomly checking for associations between variables and write paper based on statistically significant findings (data mining, data dredging)</p>

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

<p>How do we select people to be in cohort study?</p>

A

<p>-select people who are likely to be at risk of developing the outcome and are reasonable to generalize our results to

- group of people that is as representative of the people we want to study as we can</p>

  • from a well defined population
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

<p>What is random sampling?</p>

A

<p>-each person who is a member of the population has an equal probability of being selected to be a part of the study

- increases generalizability
- ensure no bias in the way we are selecting people so we get a good representation of population we want to study</p>

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

<p>What is selection bias?</p>

A

<p>-systematic difference in the way people stay in or drop out of the study or the way people are selected to stay in or leave the study
-when we lose people to follow up, we have to make sure it didn't have anything to do with their exposures they have (if they left because of that it would be significant to the study)</p>

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

<p>Importance of having equal follow up in both groups</p>

A

<p>-if we follow up with one group more than the other, we will have more data

- information bias (observational/misclassification bias): different quality of information on exposed as we do unexposed
- participants who have high levels of exposure may give you better information than people who don't so it's important to keep similar tabs on both groups to avoid getting more info from one group to another</p>

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

<p>What is ascertainment bias?</p>

A

<p>-assessor of disease status knows subjects' exposure staus</p>

-form of information bias

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

<p>What is analytic bias?</p>

A

<p>-people that are responsible for analyzing data

- they usually have no contact with participants and usually blind them to case and control status</p>

  • beliefs of investigators influence data analysis and interpretation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

<p>What are effects of biases?</p>

A

<p>-make associations appear weaker or stronger than they really are
-make associations not applicable to the population from which participants were drawn </p>

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is relative risk?

A
  • aka risk ratio
  • association between exposure and outcome in cohort study
  • (risk in exposed)/(risk in unexposed)
  • if relative risk
17
Q

In case control study, we can not calculate incidence but incidence is what we want to know. If we know disease is rare enough RR and estimate of odds are close together so there are circumstances where OR is estimate of RR (less than 25%). When RR=1, OR=1.

A
  • In case control, everyone in your study has 50% chance of getting disease because you set it up that way
  • Want to know risk—> I’m healthy today what is the chance that I will develop the disease if I do the exposure
  • Can’t do this in case control because we know all of the outcomes
18
Q

Strengths of cohort studies

A

Suitable for:

  • multiple exposures for the same disease
  • rare exposures
  • long follow up times between exposure and disease (retrospective is better for this)
  • when RCTs would be unethical (can’t randomize people to smoke or not smoke)
  • medium to long term follow up of drug performance (phase IV study)
19
Q

Weaknesses of cohort studies

A
  • long follow up for rare diseases
  • potential high drop out rate when exposure-disease interval is long
  • always potential for residual confounding (differences in age distribution, etc something affecting disease risk that isnt exposure or outcome)
  • prospective: expensive, need good hypothesis (often little justification to run the study)
  • retrospective: no control of data collection